Thus, IL-6 induces the activation of its downstream cascade JAK2/STAT3 pathway, contributing to tumorigenesis by regulating cell cycle progression, angiogenesis and tumor cell escape of the immune system (101–103). Here, JAK2 is linked to neoplasm.